NL-OMON20121招募中不适用
A multi-center, open-label, single-arm study of the Safety and Efficacy of the Percutaneous TransvenOus Mitral AnnuloplastY System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure.
Viacor, Inc.0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Moderate functional MR
- •2. Symptomatic heart failure
排除标准
- •1. MR of organic origins
- •2. Severe mitral leaflet tethering
研究者
相似试验
已完成
不适用
A pRospective, multicenter, single-arm study EvaLuating the safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment of severe asthma.Asthmalung disease10038716NL-OMON45521VAIRA, Inc10
已完成
不适用
Effect of the drug indomethacin in the treatment of COVID-19 patientsCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN11970082Indian Institute of Technology Madras250
已完成
1 期
A prospective, multi-center, single arm study – Evaluation of the safety and feasibility of MRI-guided transurethral ultrasound therapy for the ablation of prostate tissue in patients with localized prostate cancerC61Malignant neoplasm of prostateProstate CancerDRKS00005311Profound Medical Inc.30
进行中（未招募）
2 期
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe ADAtopic DermatitisNCT05905133Suzhou Connect Biopharmaceuticals, Ltd.360
已完成
2 期
Eltrombopag and Early Refractory Immune Thrombocytopenia (ITP)Blood - Haematological diseasesImmune ThrombocytopeniaACTRN12613000721707Alfred Health39